Bio-Techne Corp (TECH)

Profitability ratios

Return on sales

Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Gross profit margin 66.39% 67.80% 67.98% 68.52% 67.70% 68.02% 68.26% 68.46% 69.13% 68.79% 68.70% 68.56% 69.01% 68.11% 67.64% 67.37% 66.73% 67.32% 67.54% 67.43%
Operating profit margin 17.83% 22.45% 23.76% 26.38% 26.29% 25.33% 26.35% 25.92% 27.10% 26.74% 25.83% 25.88% 25.88% 24.85% 23.80% 23.22% 21.74% 21.81% 21.61% 21.48%
Pretax margin 16.02% 20.43% 22.24% 25.14% 29.76% 29.22% 28.38% 30.95% 28.36% 22.47% 21.18% 18.29% 16.25% 24.26% 25.96% 39.95% 38.18% 32.13% 33.01% 15.63%
Net profit margin 14.50% 17.85% 19.82% 21.80% 25.09% 24.11% 23.37% 26.13% 24.86% 21.19% 20.69% 18.18% 15.31% 22.01% 22.24% 33.29% 31.67% 25.26% 26.75% 12.96%

Based on the data provided, Bio-Techne Corp's profitability ratios have shown some fluctuations over the past few quarters.

1. Gross Profit Margin: The gross profit margin has ranged between 66.39% to 69.13% over the periods analyzed. This metric indicates the company's ability to generate profit from its revenue after accounting for the cost of goods sold.

2. Operating Profit Margin: The operating profit margin has fluctuated between 17.83% to 27.10% over the analyzed periods. This ratio reflects the company's efficiency in controlling operating expenses relative to its revenue.

3. Pre-tax Margin: The pre-tax margin has varied from 15.63% to 39.95% during the periods in review. This ratio provides insight into the company's ability to generate profits before accounting for taxes and is affected by factors such as operating efficiency and interest expenses.

4. Net Profit Margin: The net profit margin has shown fluctuations between 12.96% to 33.29% over the analyzed quarters. This metric reflects the company's efficiency in generating profit from its revenue after accounting for all expenses, including taxes.

Overall, Bio-Techne Corp's profitability ratios indicate a decent level of profitability, with some variations observed across the periods due to factors such as changes in revenue and expenses management. It is important for the company to continue monitoring and managing its profitability metrics to ensure sustained financial health.


Return on investment

Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Operating return on assets (Operating ROA) 7.64% 9.39% 9.84% 10.83% 11.33% 10.96% 12.49% 12.32% 12.92% 12.37% 11.40% 11.08% 10.49% 9.98% 9.05% 8.44% 7.76% 8.07% 7.89% 8.01%
Return on assets (ROA) 6.22% 7.46% 8.21% 8.95% 10.81% 10.44% 11.08% 12.42% 11.86% 9.80% 9.13% 7.78% 6.20% 8.84% 8.46% 12.09% 11.31% 9.35% 9.76% 4.83%
Return on total capital 9.82% 12.37% 13.53% 14.86% 17.78% 17.93% 18.01% 20.42% 18.90% 14.65% 13.37% 11.63% 10.43% 14.19% 14.54% 21.98% 21.41% 19.97% 19.77% 11.41%
Return on equity (ROE) 8.13% 10.08% 11.42% 12.35% 14.51% 14.36% 14.33% 16.67% 15.99% 13.15% 12.36% 10.77% 8.98% 11.97% 11.50% 17.25% 16.60% 14.47% 14.75% 7.93%

Bio-Techne Corp's profitability ratios have shown fluctuations over the observed periods.

1. Operating return on assets (Operating ROA) has ranged from 7.64% to 12.92% over the past few quarters, indicating the company's ability to generate operating profit from its assets, with a slight downward trend in recent periods.

2. Return on assets (ROA) has varied between 6.20% and 12.42%, reflecting the company's overall profitability in relation to its total assets, with some volatility in performance.

3. Return on total capital has ranged from 9.82% to 21.98%, displaying the company's efficiency in generating returns from its total invested capital, with a general upward trend, peaking in some periods.

4. Return on equity (ROE) has fluctuated between 8.13% and 17.25%, highlighting the company's ability to generate profits for its shareholders based on their equity investments, with notable variability in performance over time.

Overall, while Bio-Techne Corp's profitability ratios exhibit some level of inconsistency, they generally demonstrate the company's effectiveness in generating returns from its assets, capital, and equity, with periods of both strength and weakness in profitability.